Simple Summary Hepatocellular carcinoma (HCC) is a highly incident and deadly malignant
neoplasia, and only a few anti-HCC drugs are currently available. Thus, the development of …

The tumor microenvironment (TME) is shaped by dynamic metabolic and immune
interactions between precancerous and cancerous tumor cells and stromal cells like …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and shows
high global incidence and mortality rates. The liver is an immune-tolerated organ with a …

In prostate cancer, distant organ metastasis is the leading cause of patient death. Although
the mechanism of malignant tumor metastasis is unclear, studies have confirmed that …

Adoptive cell therapy (ACT) is a promising treatment that is considered safe and efficient.
Natural killer (NK) cells play an important role in the innate immune system and destroy …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and, in its
advanced stages, has a 5‐year survival rate of only 3% to 5%. Despite novel mechanisms …

Background Natural killer cells (NKC) and Sorafenib (Sor) are two important agents for the
treatment of hepatocellular carcinoma (HCC). Over the past decade, the interaction of Sor …

Аннотация На сегодняшний день терапия Т-клетками с химерным рецептором
антигена (CAR, chimeric antigen receptor) представляет собой эффективный метод …

Гепатоцеллюлярная карцинома (ГЦК) является наиболее распространенной первичной
злокачественной опухолью печени. Специфичность иммунной микросреды органа …

Gap junctions allow for direct intercellular communication between neighboring cells via
diffusion of small and hydrophilic molecules and ions. This flux, called GJIC, is crucial for the …